DRD2 and post-traumatic stress disorder: Thompson et al. (1997) and Jönsson et al. (1999) proved that individuals with the T allele show a decrease of 30–40% in DRD2 density in the striatum compared to wild-type genotype carriers, which is consistent with PTSD patients with dopamine hypoactivity (Lawford et al., 2006).